Sign inGet started

Bell Graeme

Insider CIK 1643757 · ANAC Executive VP and CFO · NTLA EVP, Chief Financial Officer

Track record PRO

XXXX$█.██M██+██%
XXXX$█.██M██+██%
XXXX$█.██M██+██%
Track record
See how this insider's past purchases performed 30 and 90 days later, and a conviction score on each buy.
Upgrade to Pro · $99/yearAlready Pro? Log in

Trades across companies

TickerCodeTradeFiledSharesPriceValueOwned after
NTLA Intellia Therapeutics, Inc M Exercise deriv2018-03-282018-03-308,000— $0202,000SEC↗
NTLA Intellia Therapeutics, Inc M Exercise2018-03-282018-03-308,000$13.48 $107.8K21,400SEC↗
NTLA Intellia Therapeutics, Inc A Award deriv2018-01-252018-01-2925,000— $025,000SEC↗
NTLA Intellia Therapeutics, Inc A Award deriv2017-12-122017-12-1472,500— $072,500SEC↗
NTLA Intellia Therapeutics, Inc A Award2017-11-032017-11-035,000$22.04 $110.2K13,400SEC↗
NTLA Intellia Therapeutics, Inc A Award2017-06-022017-06-058,400$12.37 $103.9K8,400SEC↗
NTLA Intellia Therapeutics, Inc A Award deriv2017-01-032017-01-05210,000— $0210,000SEC↗
ANAC Anacor Pharmaceuticals, In D To issuer deriv2016-06-242016-06-2425,299— $00SEC↗
ANAC Anacor Pharmaceuticals, In D To issuer deriv2016-06-242016-06-2428,793— $00SEC↗
ANAC Anacor Pharmaceuticals, In D To issuer deriv2016-06-242016-06-245,000— $00SEC↗
ANAC Anacor Pharmaceuticals, In D To issuer deriv2016-06-242016-06-244,004— $00SEC↗
ANAC Anacor Pharmaceuticals, In D To issuer deriv2016-06-242016-06-248,008— $00SEC↗
ANAC Anacor Pharmaceuticals, In D To issuer2016-06-242016-06-2410,488$99.25 $1.04M0SEC↗
ANAC Anacor Pharmaceuticals, In S Sale2016-06-012016-06-03751$99.28 $74.6K10,255SEC↗
ANAC Anacor Pharmaceuticals, In A Award deriv2016-02-032016-02-055,000— $05,000SEC↗
ANAC Anacor Pharmaceuticals, In A Award deriv2016-02-032016-02-0525,299— $025,299SEC↗
ANAC Anacor Pharmaceuticals, In A Award2016-02-032016-02-055,000— $011,006SEC↗
ANAC Anacor Pharmaceuticals, In A Award deriv2015-06-012015-06-038,008— $08,008SEC↗
ANAC Anacor Pharmaceuticals, In A Award deriv2015-06-012015-06-0328,793— $028,793SEC↗
ANAC Anacor Pharmaceuticals, In A Award deriv2015-06-012015-06-034,004— $04,004SEC↗
ANAC Anacor Pharmaceuticals, In A Award2015-06-012015-06-036,006— $06,006SEC↗